| Dr Marcia Liu, MD | |
|
11 Meridian Rd, Eatontown, NJ 07724-2242 | |
| (732) 663-0300 | |
| (732) 663-0301 |
| Full Name | Dr Marcia Liu |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 32 Years |
| Location | 11 Meridian Rd, Eatontown, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144294737 | NPI | - | NPPES |
| 8996407 | Medicaid | NJ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centrastate Medical Center | Freehold, NJ | Hospital |
| Ocean Medical Center | Brick, NJ | Hospital |
| Jersey Shore University Medical Center | Neptune, NJ | Hospital |
| Saint Peter's University Hospital | New brunswick, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Monmouth Cardiology Associates, Llc | 6901881200 | 39 |
News Archive
The pursuit of true happiness can lead people to lifestyles that will not only be satisfying but will be better for the environment, according to an overview of psychological research presented at the American Psychological Association's 122nd Annual Convention.
GE Healthcare, a unit of General Electric Company, today announced it has reached an agreement to acquire PAA Laboratories, a developer and supplier of cell culture media for biomedical research and the fast-growing biopharmaceutical and vaccine manufacturing industry.
Belgian chemists have developed "self-exploding" microcapsules that could one day precisely release drugs and vaccines inside the human body weeks or even months after injection.
Taking omega-3 fish oils could help to protect against skin cancer, according to researchers at The University of Manchester.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
› Verified 3 days ago
| Entity Name | Monmouth Cardiology Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285601674 PECOS PAC ID: 6901881200 Enrollment ID: O20040621001822 |
News Archive
The pursuit of true happiness can lead people to lifestyles that will not only be satisfying but will be better for the environment, according to an overview of psychological research presented at the American Psychological Association's 122nd Annual Convention.
GE Healthcare, a unit of General Electric Company, today announced it has reached an agreement to acquire PAA Laboratories, a developer and supplier of cell culture media for biomedical research and the fast-growing biopharmaceutical and vaccine manufacturing industry.
Belgian chemists have developed "self-exploding" microcapsules that could one day precisely release drugs and vaccines inside the human body weeks or even months after injection.
Taking omega-3 fish oils could help to protect against skin cancer, according to researchers at The University of Manchester.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Marcia Liu, MD 11 Meridian Rd, Eatontown, NJ 07724-2242 Ph: (732) 663-0300 | Dr Marcia Liu, MD 11 Meridian Rd, Eatontown, NJ 07724-2242 Ph: (732) 663-0300 |
News Archive
The pursuit of true happiness can lead people to lifestyles that will not only be satisfying but will be better for the environment, according to an overview of psychological research presented at the American Psychological Association's 122nd Annual Convention.
GE Healthcare, a unit of General Electric Company, today announced it has reached an agreement to acquire PAA Laboratories, a developer and supplier of cell culture media for biomedical research and the fast-growing biopharmaceutical and vaccine manufacturing industry.
Belgian chemists have developed "self-exploding" microcapsules that could one day precisely release drugs and vaccines inside the human body weeks or even months after injection.
Taking omega-3 fish oils could help to protect against skin cancer, according to researchers at The University of Manchester.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
› Verified 3 days ago